Related Experiment Video
Updated: Aug 7, 2026
08:41
Visualizing the DNA Damage Response in Purkinje Cells Using Cerebellar Organotypic Cultures
Published on: December 27, 2024
Survival probability in ataxia telangiectasia
T O Crawford1, R L Skolasky, R Fernandez
1Department of Neurology, The Johns Hopkins Hospital, Baltimore, Maryland 21287, USA. tcrawfo@jhmi.edu
Archives of Disease in Childhood
|June 23, 2006
Summary
Ataxia telangiectasia (AT), a rare neurodegenerative disorder, affects multiple organs and increases cancer and infection risks. Patient survival varies, with median lifespans of 25 and 19 years in different studies, independent of neurological symptom severity.
Area of Science:
- Neurology
- Genetics
- Oncology
Background:
- Ataxia telangiectasia (AT) is a rare, inherited neurodegenerative disorder.
- It affects multiple organ systems and predisposes individuals to cancer and infections.
- Understanding AT's impact on lifespan is crucial for patient care and research.
Purpose of the Study:
- To analyze survival data in patients diagnosed with Ataxia telangiectasia.
- To determine the median life expectancy for individuals with AT.
- To investigate the correlation between neurological impairment severity and life expectancy in AT patients.
Main Methods:
- Analysis of patient data from two distinct cohorts: one prospective and one retrospective.
- Statistical evaluation of survival times and median lifespan.
- Assessment of the relationship between neurological symptom severity and patient survival.
Main Results:
- Median survival was 25 years in the prospective cohort and 19 years in the retrospective cohort.
- A wide range of survival times was observed within both cohorts.
- Life expectancy did not show a strong correlation with the severity of neurological impairment.
Conclusions:
- Survival in Ataxia telangiectasia patients exhibits significant variability.
- Neurological impairment severity is not a reliable predictor of life expectancy in AT.
- Further research is needed to understand factors influencing survival in this complex disorder.
Related Concept Videos
02:36DNA Damage can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
02:36DNA Damage Can Stall the Cell Cycle
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:15Replicative Cell Senescence
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds the telomeric...
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...